Brooklyn, NY, United States of America

Benjamin Edward Birnbaum

USPTO Granted Patents = 7 

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 60(Granted Patents)


Location History:

  • Brookyln, NY (US) (2020)
  • Brooklyn, NY (US) (2019 - 2023)
  • New York, NY (US) (2023)

Company Filing History:


Years Active: 2019-2024

Loading Chart...
7 patents (USPTO):

Title: Innovations of Benjamin Edward Birnbaum

Introduction

Benjamin Edward Birnbaum is a notable inventor based in Brooklyn, NY. He has made significant contributions to the field of biomarker modeling and cohort selection, holding a total of 7 patents. His work focuses on developing systems that enhance the identification and monitoring of cohorts based on biomarker data.

Latest Patents

One of his latest patents is titled "Generalized biomarker model." This invention describes a model-assisted system for identifying candidates for a cohort based on a biomarker. The system includes a processor programmed to access a database containing information about a population of individuals. It provides a first biomarker associated with a cohort, which is trained using one or more second biomarkers. The processor then determines whether an individual from the identified group is a candidate for the cohort based on the likelihood of having been tested for the first biomarker.

Another significant patent is focused on "Systems and methods for automatic bias monitoring of cohort models and un-deployment of biased models." This invention outlines a system for automatically assessing a deployed model for cohort selection. The system applies the model to data representing a plurality of individuals and selects a subset as a cohort. It then compares this subset with another labeled group to determine if there is a significant difference in characteristics, ensuring the integrity of the cohort selection process.

Career Highlights

Benjamin Edward Birnbaum is currently employed at Flatiron Health, Inc., where he continues to innovate in the field of healthcare technology. His work is instrumental in improving the accuracy and fairness of cohort selection processes in medical research.

Collaborations

He collaborates with talented individuals such as Nathan Coleman Nussbaum and Joshua Daniel Haimson, contributing to advancements in their shared field of expertise.

Conclusion

Benjamin Edward Birnbaum's contributions to biomarker modeling and cohort selection are paving the way for more effective healthcare solutions. His innovative patents reflect a commitment to enhancing the accuracy and fairness of medical research methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…